Gene · 8658
Papers2,155
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,155
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| WNT signaling in cancer: molecular mechanisms and potential therapies. | Mol Biomed | 2025 | 41120801 | PubTator, text mining | PubMed |
| Phosphorylation as a candidate regulatory mechanism for effector recruitment to tankyrase. | R Soc Open Sci | 2025 | 41103766 | PubTator, text mining | PubMed |
| Role of tankyrase scaffolding in the β-catenin destruction complex and WNT signaling. | bioRxiv | 2025 | 41040241 | PubTator, text mining | PubMed |
| Tankyrases positively regulate influenza A virus replication via type I interferon response. | J Virol | 2025 | 41036852 | PubTator, text mining | PubMed |
| Generating human primordial germ cell-like cells from pluripotent stem cells: a scoping review of in vitro methods. | Hum Reprod Open | 2025 | 41018120 | PubTator, text mining | PubMed |
| The brief resilience scale: a genome-wide association study in the UK Biobank. | BMC Med | 2025 | 41013467 | PubTator, text mining | PubMed |
| Structural stability-guided scaffold hopping and computational modeling of tankyrase inhibitors targeting colorectal cancer. | PLoS One | 2025 | 40971369 | PubTator, text mining | PubMed |
| A First-In-Human Dose-Escalation Phase I Study of Basroparib, a Tankyrase Inhibitor, in Patients with Advanced-Stage Solid Tumors. | Cancer Res Commun | 2025 | 40964966 | PubTator, text mining | PubMed |
| JPI-547, a Dual Inhibitor of PARP/Tankyrase, Shows Antitumor Activity Against Pancreatic Cancers with Homologous Recombination Repair Deficiency or Wnt-Addiction. | Int J Biol Sci | 2025 | 40959288 | PubTator, text mining | PubMed |
| A machine learning-Assisted QSAR and integrative computational combined with network pharmacology approach for rational identification of tankyrase inhibitors in colon adenocarcinoma. | Comput Biol Med | 2025 | 40945215 | PubTator, text mining | PubMed |
| Defined Xenofree Reprogramming of Cord Blood Progenitors to Induced Pluripotent and Blastomere-Like Stem Cells. | J Vis Exp | 2025 | 40920620 | PubTator, text mining | PubMed |
| PARP (Poly ADP-ribose Polymerase) Family in Health and Disease. | MedComm (2020) | 2025 | 40904702 | PubTator, text mining | PubMed |
| Deltex and RING-UIM E3 ligases cooperate to create a ubiquitin-ADP-ribose hybrid mark on tankyrase, promoting its stabilization. | Sci Adv | 2025 | 40901936 | PubTator, text mining | PubMed |
| A pathogenic variant of AMOT leads to isolated X-linked congenital hydrocephalus due to N-terminal truncation. | J Clin Invest | 2025 | 40892511 | PubTator, text mining | PubMed |
| The role of ASS1 in mouse embryonic stem cell differentiation into mesendoderm lineages. | Stem Cell Res Ther | 2025 | 40890876 | PubTator, text mining | PubMed |
| Glucose Metabolic Reprogramming in Colorectal Cancer: From Mechanisms to Targeted Therapy Approaches. | Cancer Med | 2025 | 40884151 | PubTator, text mining | PubMed |
| Intron turnover of slc26a1 and slc26a2 and convergence of intron insertion sites. | Sci Rep | 2025 | 40819135 | PubTator, text mining | PubMed |
| Wnt/β-Catenin Signaling Regulates Hepatitis B Virus cccDNA Levels. | Int J Mol Sci | 2025 | 40725188 | PubTator, text mining | PubMed |
| Selective Dual Inhibition of TNKS1 and CDK8 by TCS9725 Attenuates STAT1/β-Catenin/TGFβ1 Signaling in Renal Cancer. | Curr Issues Mol Biol | 2025 | 40699862 | PubTator, text mining | PubMed |
| Practice-Level Clustering of Industry Payments to Clinicians. | Health Serv Res | 2025 | 40571952 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8658/papers?page=3